Breast Cancer,Other Cancers Capivasertib and Fulvestrant for Pts With AI-Resistant HR+/HER2 ABC Jul 28, 2023
Other Cancers Efficacy and Safety of Ixazomib and Daratumumab without Dexamethasone (I-DARA) in Elderly Frail RRMM Patients Jul 28, 2023
Lymphoma,Other Cancers Pembrolizumab as First Treatment for CHL in Older or ABVD-Ineligible Patients Jul 27, 2023
Lymphoma,Other Cancers Baseline PET Radiomics Predicts PMBCL Better Than Clinical Risk Scores Jul 27, 2023
